Ensign Peak Advisors’s Diebold Nixdorf Incorporated DBD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-35,920
Closed -$242K 2229
2022
Q1
$242K Hold
35,920
﹤0.01% 1824
2021
Q4
$325K Sell
35,920
-21,380
-37% -$199K ﹤0.01% 1787
2021
Q3
$579K Hold
57,300
﹤0.01% 1592
2021
Q2
$736K Hold
57,300
﹤0.01% 1518
2021
Q1
$810K Buy
57,300
+17,100
+43% +$235K ﹤0.01% 1489
2020
Q4
$429K Buy
40,200
+34,400
+593% +$312K ﹤0.01% 1628
2020
Q3
$44K Buy
+5,800
New +$42.7K ﹤0.01% 1729
2020
Q1
Sell
-68,900
Closed -$728K 1704
2019
Q4
$728K Buy
+68,900
New +$612K ﹤0.01% 1439

Other funds holding DBD

Ensign Peak Advisors's DBD Position: Q2 2022 in Review

Ensign Peak Advisors sold out of Diebold Nixdorf Incorporated (DBD) in Q2 2022, closing a stake of 35,920 shares — an estimated $242K sold.

Ensign Peak Advisors first reported a position in DBD in Q4 2019 and held it in 8 quarters. The position peaked at $810K in Q1 2021. 169 funds tracked by Wall St. Rank hold DBD as of Q2 2022.

  • Ensign Peak Advisors reported no remaining Diebold Nixdorf Incorporated position as of Q2 2022 after selling out during the quarter.
  • Ensign Peak Advisors sold 35,920 Diebold Nixdorf Incorporated shares in Q2 2022, an estimated $242K.
  • Ensign Peak Advisors first reported a position in Diebold Nixdorf Incorporated in Q4 2019 and held it in 8 quarters.
  • Ensign Peak Advisors's Diebold Nixdorf Incorporated position peaked at $810K in Q1 2021.
  • 169 funds tracked by Wall St. Rank held Diebold Nixdorf Incorporated as of Q2 2022.

Based on Ensign Peak Advisors's 13F filing for Q2 2022, filed 12 Aug 2022.